These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1279848)
21. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction. Wilasrusmee C; Da Silva M; Singh B; Siddiqui J; Bruch D; Kittur S; Wilasrusmee S; Kittur DS Clin Transplant; 2003; 17 Suppl 9():6-12. PubMed ID: 12795661 [TBL] [Abstract][Full Text] [Related]
22. Pentoxifylline decreases cyclosporine-induced renal endothelin release and vasoconstriction. Carrier M; Perrault LP; Tronc F; Stewart DJ; Pelletier CL Ann Thorac Surg; 1993 Feb; 55(2):490-2. PubMed ID: 8431065 [TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A, but not FK506, increases arachidonic acid release and inhibits proliferation of pituitary corticotrope tumor cells. Pompeo A; Baldassare M; Luini A; Buccione R Life Sci; 1999; 64(10):837-46. PubMed ID: 10096434 [TBL] [Abstract][Full Text] [Related]
24. Effect of cyclosporin and tacrolimus (FK506) on the antigen-induced mediator release, membrane potential and 86Rb+/K+ and Ca2+ fluxes in the RBL-2H3 cell line. Narenjkar J; Assem el-SK; Wan BY; Marsh S; Ezeamuzie CI Int Immunopharmacol; 2006 May; 6(5):742-9. PubMed ID: 16546704 [TBL] [Abstract][Full Text] [Related]
25. Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro. Yatscoff RW; Fryer J; Thliveris JA Clin Biochem; 1993 Oct; 26(5):409-14. PubMed ID: 7507804 [TBL] [Abstract][Full Text] [Related]
26. CsA and FK506 up-regulate eNOS expression: role of reactive oxygen species and AP-1. Navarro-Antolín J; Hernández-Perera O; López-Ongil S; Rodríguez-Puyol M; Rodríguez-Puyol D; Lamas S Kidney Int Suppl; 1998 Dec; 68():S20-4. PubMed ID: 9839278 [TBL] [Abstract][Full Text] [Related]
27. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Andersson J; Nagy S; Groth CG; Andersson U Immunology; 1992 Jan; 75(1):136-42. PubMed ID: 1371491 [TBL] [Abstract][Full Text] [Related]
28. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Textor SC; Wiesner R; Wilson DJ; Porayko M; Romero JC; Burnett JC; Gores G; Hay E; Dickson ER; Krom RA Transplantation; 1993 Jun; 55(6):1332-9. PubMed ID: 7685934 [TBL] [Abstract][Full Text] [Related]
29. The role of endothelin in FK506-induced vascular reactivity changes in rat perfused kidney. Tekes E; Soydan G; Tuncer M Eur J Pharmacol; 2005 Jul; 517(1-2):92-6. PubMed ID: 15964565 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of FK506 and cyclosporine A on the growth and invasion of human liver cancer cells. Sakai M; Miyake H; Tashiro S; Okumura Y; Kido H J Med Invest; 2004 Feb; 51(1-2):63-9. PubMed ID: 15000258 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Hafizi S; Mordi VN; Andersson KM; Chester AH; Yacoub MH Vascul Pharmacol; 2004; 41(4-5):167-76. PubMed ID: 15607500 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. Gabryel B; Chalimoniuk M; Stolecka A; Waniek K; Langfort J; Malecki A J Pharmacol Sci; 2006 Sep; 102(1):77-87. PubMed ID: 16990701 [TBL] [Abstract][Full Text] [Related]
33. Cyclosporine A- and FK506-induced apoptosis in PC12 cells. Takadera T; Sakamoto Y; Hizume Y; Ohyashiki T Cell Biol Toxicol; 2007 Sep; 23(5):355-60. PubMed ID: 17385075 [TBL] [Abstract][Full Text] [Related]
34. The direct effect of injectable cyclosporine and its vehicle, cremophor, on endothelial vascular cell adhesion molecule-1 expression. Ricinoleic acid inhibits coronary artery endothelial activation. De Caterina R; Tanaka H; Nakagawa T; Hauptman PJ; Libby P Transplantation; 1995 Aug; 60(3):270-5. PubMed ID: 7544037 [TBL] [Abstract][Full Text] [Related]
35. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling. El-Mas MM; Helmy MW; Ali RM; El-Gowelli HM Toxicol Appl Pharmacol; 2015 Apr; 284(1):1-7. PubMed ID: 25656942 [TBL] [Abstract][Full Text] [Related]
36. Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Garcia-Maldonado M; Kaufman CE; Comp PC Transplantation; 1991 Mar; 51(3):701-5. PubMed ID: 1848730 [TBL] [Abstract][Full Text] [Related]
37. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide? Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743 [TBL] [Abstract][Full Text] [Related]
38. [Effects of tacrolimus and cyclosporine on albumin secretion in cultured human hepatocyte]. Li Y; Liu ZH; Huang YF; Li LS; Liu FY; Peng YM Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):387-91. PubMed ID: 16859130 [TBL] [Abstract][Full Text] [Related]
39. Additive effects of oxidized low-density lipoproteins and cyclosporine on endothelin-1 production of renal arterial endothelial cells. Enderlein M; Gross P Transplant Proc; 2003 Jun; 35(4):1581-3. PubMed ID: 12826225 [No Abstract] [Full Text] [Related]
40. The role of testosterone in cyclosporine-induced osteopenia. Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]